About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Gastrointestinal Cancers
Genitourinary Cancers
Hematologic Malignancies
Lung Cancers
Breast Cancers
General Oncology
Palliative Care
Business & Clinical Practice
Event
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Immunotherapy in NSCLC: Progression, irAE management & Combination Therapies
By
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
FEATURING
Ravi Salgia
By
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
FEATURING
Ravi Salgia
509 views
March 12, 2020
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
20:59
Exelixis
Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…
Feat.
S. Ratnam
Lung Cancers
09:53
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
2L Options for EGFR+ NSCLC: How to Treat Osimertinib Resistance? Wha…
Feat.
S. Kazmi
15:37
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Update on Early Stage NSCLC: Role of Screening, Neoadjuvant Therapie…
Feat.
J. Porter
10:32
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Use of Stereotactic Radiation for NSCLC Pts & Vale of IO after S…
Feat.
W. Curran
09:04
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
New RT Approaches to Stage III NSCLC Pts: Can Radiotherapy Be Furthe…
Feat.
W. Curran
10:53
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
2020 Update on NSCLC Targeted Therapies: ALK, ROS1, RET, MET, NTRK, …
Feat.
S. Kazmi
14:33
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Immunotherapy in NSCLC: Progression, irAE management & Combinati…
Feat.
R. Salgia